Tislelizumab in combination with gemcitabine plus cisplatin chemotherapy as first-line adjuvant treatment for locally advanced or metastatic bladder cancer: a retrospective study

Xiang Ren(University of Electronic Science and Technology of China), Yiqun Tian(Tongji Hospital), Zhixian Wang(Harbin Institute of Technology), Xing Li(Tongji Hospital), Ruibao Chen(Tongji Hospital), Ying Zhan(Hebei Medical University), Yisheng Yin(Nanjing University), Jing Wang(Inserm)
Research Square
May 16, 2022
Cited by 4


Related Papers